Geode Capital Management »

Black Diamond Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 383k 5.07
2023-09-30 $931k 324k 2.87
2023-06-30 $1.4M 271k 5.05
2023-03-31 $511k 270k 1.89
2022-12-31 $477k 265k 1.80
2022-09-30 $447k 265k 1.69
2022-06-30 $606k 247k 2.46
2022-03-31 $1.2M 432k 2.77
2021-12-31 $2.1M 396k 5.33
2021-09-30 $3.0M 350k 8.46
2021-06-30 $4.4M 360k 12.19
2021-03-31 $7.2M 297k 24.26
2020-12-31 $8.7M 270k 32.05
2020-09-30 $7.5M 248k 30.23
2020-06-30 $7.7M 182k 42.16
2020-03-31 $2.3M 90k 24.95